Real World Outcomes with Evolving Management of Cytokine Release Syndrome in CAR-T Therapy

被引：0
|
作者：
Bansal, Radhika [1 ]
Corraes, Andre [2 ]
Shaw, Monica [2 ]
Holmes, Lucy [3 ]
Kosobud, Allison [3 ]
Haugen, Kelsey L. [4 ]
Khurana, Arushi [2 ]
Hampel, Paul J. [2 ]
Durani, Urshila [2 ]
Hayman, Suzanne R. [2 ]
Wang, Yucai [2 ]
Binder, Moritz [2 ]
Paludo, Jonas [2 ]
Kenderian, Saad S. [2 ]
Bennani, N. Nora [2 ]
Johnston, Patrick B. [4 ]
Ansell, Stephen M. [2 ]
Lin, Yi [2 ]
机构：
[1] Zucker Sch Med Hofstra Northwell Lenox Hill, Internal Med, New York, NY USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Dept Med, Div Hematol, Rochester, MN USA
[4] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2274 / 2275
页数：2
相关论文
共 50 条
  • [1] Management of cytokine release syndrome related to CAR-T cell therapy
    Hongli Chen
    Fangxia Wang
    Pengyu Zhang
    Yilin Zhang
    Yinxia Chen
    Xiaohu Fan
    Xingmei Cao
    Jie Liu
    Yun Yang
    Baiyan Wang
    Bo Lei
    Liufang Gu
    Ju Bai
    Lili Wei
    Ruili Zhang
    Qiuchuan Zhuang
    Wanggang Zhang
    Wanhong Zhao
    Aili He
    Frontiers of Medicine, 2019, 13 : 610 - 617
  • [2] Management of cytokine release syndrome related to CAR-T cell therapy
    Chen, Hongli
    Wang, Fangxia
    Zhang, Pengyu
    Zhang, Yilin
    Chen, Yinxia
    Fan, Xiaohu
    Cao, Xingmei
    Liu, Jie
    Yang, Yun
    Wang, Baiyan
    Lei, Bo
    Gu, Liufang
    Bai, Ju
    Wei, Lili
    Zhang, Ruili
    Zhuang, Qiuchuan
    Zhang, Wanggang
    Zhao, Wanhong
    He, Aili
    FRONTIERS OF MEDICINE, 2019, 13 (05) : 610 - 617
  • [3] Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
    Wang, Zhenguang
    Han, Weidong
    BIOMARKER RESEARCH, 2018, 6
  • [4] Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy
    Balagopal, Srinivas
    Sasaki, Koichi
    Kaur, Pooja
    Nikolaidi, Maria
    Ishihara, Jun
    JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (37) : 7491 - 7511
  • [5] CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY IN CAR-T CELL THERAPY PATIENTS
    Delrosario, Maria Regina
    Davison, Lisa
    Schwen, Sarah
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [6] Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
    Zhenguang Wang
    Weidong Han
    Biomarker Research, 6
  • [7] CUTANEOUS MANIFESTATIONS OF CYTOKINE RELEASE SYNDROME FOLLOWING CAR-T CELL THERAPY
    Li, S.
    Ringus, D.
    Grammer, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S105 - S105
  • [8] Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
    Ferreros, Puri
    Trapero, Isabel
    DISEASES, 2022, 10 (03)
  • [9] Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy
    Gu, Chengyuan
    Wu, Qian
    Zhang, Jingren
    Kang, Liqing
    Yu, Lei
    Qiu, Huiying
    Wu, Depei
    Chen, Suning
    Yang, Xiaofei
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 495 - 498
  • [10] Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
    Chou, Cassie K.
    Turtle, Cameron J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 653 - 664
12345